Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-20-002597
Filing Date
2020-02-28
Accepted
2020-02-28 16:39:19
Documents
2
Period of Report
2020-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 11204
2 ex24hall.txt EX-24 3889
  Complete submission text file 0001179110-20-002597.txt   16561
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ESPERION THERAPEUTICS INC. 3891 RANCHERO DRIVE SUITE 150 ANN ARBOR MI 48108
Business Address
Hall Ashley (Reporting) CIK: 0001801842 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 20671123